Robert Picone R.Ph., Ph.D.

Robert Picone R.Ph., Ph.D. has a diverse work experience spanning over three decades. Robert is currently working as a Field Medical Scientist at Provention Bio since April 2021. Prior to this, they served as the Addiction Medical Science Director at Alkermes from January 2017. Robert also worked as an Assistant Professor, Adjunct at UCONN, School of Pharmacy starting in 2015.

From 2012 to 2017, Robert served as a Medical Liaison-Diabetes at Novo Nordisk A/S. Before that, they held a significant role as an Executive Respiratory/Cardiovascular Metabolic Science Specialist at Merck & Co., Inc. from June 2007 to September 2012. During their time at Merck & Co., Inc., they received several awards and recognition for their team-playing skills and contribution to the company's success.

Additionally, Robert worked as a Scientific Liaison at the Center for Drug Discovery-The Univeristy of Connecticut from January 2002 to December 2004, where they facilitated collaborative efforts with renowned Thought Leaders/Principal Investigators. Robert also presented scientific materials at national and international research conferences and provided coaching to colleagues.

Earlier in their career, Robert gained experience as a Clinical Pharmacist at Windham Hospital/Hartford Healthcare Partner from 1997 to 1999, and as a Senior Pharmacist at CVS Pharmacy from 1994 to 1996. Robert also had the opportunity to work as a COSTEP Summer Research Fellow at FDA-Center for Biologics Evaluation & Research in 1992. Robert started their career as an Intern at Brooks Eckerd Pharmacy from 1989 to 1990.

Overall, Robert Picone R.Ph., Ph.D. has a wide range of experience in various pharmaceutical and healthcare roles, including medical science, academia, and clinical practice.

Robert Picone R.Ph., Ph.D. began their education in 1989, completing their Bachelor's degree in Pharmacy with Honors Scholar and Cum Laude distinctions at the University of Connecticut in 1994. Afterward, they pursued further studies in Molecular Pharmacology, earning their Ph.D. from the University of Connecticut in 2001.